On June 29, the United States Supreme Court issued a ruling that reverses 45 years of legal precedent in admissions at institutions of higher learning, striking a death blow to affirmative action.
Today’s critical shortage of cisplatin and carboplatin occurred because manufacturers failed to invest in enhancing production capacity, Richard Pazdur, director of the FDA Oncology Center of Excellence and acting director of the Office of Oncologic Diseases, said to The Cancer Letter.
The shortage of platinum-based drugs in the United States is an endemic problem—i.e., Europe is unaffected—caused by the absence of transparency, dearth of early warnings, and a lack of redundancy in the supply chain.
Leukemia was mostly a fatal disease when Hagop Kantarjian, a medical student at the American University of Lebanon in Beirut, first came to MD Anderson in 1978.
The U.S. Preventive Services Task Force’s latest draft recommendation on breast cancer screening is based in part on data on racial disparities in breast cancer mortality.